multitarget neuroprotectant
- Health
GNT Pharma Announces Positive Top-Line Results in a Phase II Study of Nelonemdaz for Acute Ischemic Stroke Patients Treated With Endovascular Thrombectomy
Yongin, South Korea: Safety and Tolerability Established Good and Excellent Functional Outcome Increased GNT Pharma Inc. today reports positive top-line results…
Read More »